119 related articles for article (PubMed ID: 18196927)
1. Tenascin-C expression and its prognostic significance in colorectal cancer.
Lundin M; Nordling S; Lundin J; Haglund C
Oncology; 2007; 72(5-6):403-9. PubMed ID: 18196927
[TBL] [Abstract][Full Text] [Related]
2. Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.
Lundin M; Nordling S; Lundin J; Isola J; Wiksten JP; Haglund C
Oncology; 2005; 68(4-6):306-13. PubMed ID: 16020957
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
4. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.
Juuti A; Nordling S; Louhimo J; Lundin J; Haglund C
J Clin Pathol; 2004 Nov; 57(11):1151-5. PubMed ID: 15509674
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A
APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
[TBL] [Abstract][Full Text] [Related]
9. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
10. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
[TBL] [Abstract][Full Text] [Related]
11. Profiling markers of prognosis in colorectal cancer.
Lyall MS; Dundas SR; Curran S; Murray GI
Clin Cancer Res; 2006 Feb; 12(4):1184-91. PubMed ID: 16489072
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
15. Significance of tenascin-C, fibronectin, laminin, collagen IV, alpha5beta1 and alpha9beta1 integrins and fibrotic capsule formation around liver metastases originating from cancers of the digestive tract.
Gulubova MV; Vlaykova TI
Neoplasma; 2006; 53(5):372-83. PubMed ID: 17013531
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
17. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C in primary malignant melanoma of the skin.
Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
[TBL] [Abstract][Full Text] [Related]
20. The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.
Essapen S; Thomas H; Green M; De Vries C; Cook MG; Marks C; Topham C; Modjtahedi H
Int J Oncol; 2004 Feb; 24(2):241-8. PubMed ID: 14719098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
